Ignite Creation Date:
2025-12-24 @ 4:16 PM
Ignite Modification Date:
2026-05-09 @ 11:57 PM
Study NCT ID:
NCT02988466
Status:
COMPLETED
Last Update Posted:
2025-05-28
First Post:
2016-12-07
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Reduced Intensity (RIC) Conditioning And Transplantation of HLA-Haplo-HCT
Sponsor:
Masonic Cancer Center, University of Minnesota
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Hematologic Malignancies | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Acute Leukemias | View |
| None | Acute myeloid leukemia (AML) | View |
| None | Acute lymphoblastic leukemia (ALL)/lymphoma | View |
| None | Biphenotypic/Undifferentiated/Prolymphocytic Leukemias | View |
| None | Myelodysplastic syndrome | View |
| None | Chronic myelogenous leukemia | View |
| None | Minimal Residual Disease (MRD) positive leukemia | View |
| None | Leukemia or Myelodysplastic Syndromes (MDS) in aplasia | View |
| None | Myeloproliferative neoplasms/myelofibrosis | View |
| None | Relapsed large-cell lymphoma, mantle-cell lymphoma and Hodgkin lymphoma | View |
| None | Burkitt's lymphoma | View |
| None | Relapsed T-cell lymphoma | View |
| None | Natural Killer cell malignancies | View |
| None | Relapsed chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), marginal zone B-cell … | View |
| None | Lymphoplasmacytic lymphoma | View |
| None | Relapsed multiple myeloma | View |
| None | Bone marrow failure syndromes | View |